| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/11/2006 | WO2002094997A3 Transcriptional regulation of target genes |
| 05/11/2006 | WO2002055100A9 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 05/11/2006 | US20060101530 Rors as modifiers of the p21 pathway and methods of use |
| 05/11/2006 | US20060100431 Biologically active compounds |
| 05/11/2006 | US20060100285 N-hydroxy-4-[2-(4-trifluoromethyl-phenyl)-acetylamino]-benzamide for example; treating infammatory, autoimmune diseases, tumors, and neurodegenerative diseases |
| 05/11/2006 | US20060100280 Cell growth regulator |
| 05/11/2006 | US20060100261 Furan or thiopene derivative and medicinal use thereof |
| 05/11/2006 | US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt |
| 05/11/2006 | US20060100240 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 05/11/2006 | US20060100238 4',7-Dihydroxyisoflavanone (phenyl)hydrazone; 4,7-Dihydroxyisoflavanone(4,7-dihydroxyisoflavanone)hydrazone; anticarcinogenic and antiinflammatory agents; cyclooxygenase inhibitor |
| 05/11/2006 | US20060100233 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/11/2006 | US20060100227 Pyrimidine derivaties |
| 05/11/2006 | US20060100211 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/11/2006 | US20060100202 Novel compounds |
| 05/11/2006 | US20060100199 Novel condensed imidazole derivatives |
| 05/11/2006 | US20060100166 Compounds for modulating the activity of exchange proteins directly activated by camp (epacs) |
| 05/11/2006 | US20060100150 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 05/11/2006 | US20060100140 Combination of a) n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]2-methylphenyl}-4- (3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia |
| 05/11/2006 | US20060099658 PCA3, PCA3 genes, and methods of use |
| 05/11/2006 | US20060099652 IL 13 receptor alpha 2 antibody and methods of use |
| 05/11/2006 | US20060099635 Anti-GL50 antibodies |
| 05/11/2006 | US20060099265 Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 05/11/2006 | US20060099224 Methods and compositions concerning poxviruses and cancer |
| 05/11/2006 | US20060099219 Mutated hpv-16e7 polypeptide, pharmaceutical composition comprising it and its preparation process |
| 05/11/2006 | US20060099218 Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity |
| 05/11/2006 | US20060099209 prostate and breast carcinoma; used for diagnosis to identify individuals with the high probability of having a malignant disease |
| 05/11/2006 | US20060099202 Immunoglobulin construct containing tumor- specific p53bp2 sequenes for eliciting an anti-tumor response |
| 05/11/2006 | US20060099189 Anti-cancer virus desensitization method |
| 05/11/2006 | US20060099188 Tumor-specific promoter |
| 05/11/2006 | US20060099178 Novel use of adenoviruses and nucleic acids coding therefor |
| 05/11/2006 | US20060099174 Interferon-alpha induced genes |
| 05/11/2006 | US20060099150 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 05/11/2006 | US20060099143 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis |
| 05/11/2006 | DE3571648C5 Monoklonale Antikörper gegen menschlichen Brustkrebs, ihre Produktion und Verwendung, Hybridomen zu ihrer Herstellung und Herstellung dieser Hybridomen. Monoclonal antibodies against human breast cancer, their production and use, hybridomas for their preparation and production of these hybridomas. |
| 05/11/2006 | DE102004054216A1 Substituierte 4-Amino-pyridopyrimidinone Substituted 4-amino-pyridopyrimidinone |
| 05/11/2006 | DE102004054215A1 Pyridopyrimidinonderivate Pyridopyrimidinonderivate |
| 05/11/2006 | CA2588278A1 Anthranilamide pyridinureas as vascular endothelial growth factor (vegf)receptor kinase inhibitors |
| 05/11/2006 | CA2587489A1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/11/2006 | CA2586602A1 Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives |
| 05/11/2006 | CA2586259A1 Novel fused imidazole derivative |
| 05/11/2006 | CA2586177A1 Polymorphic forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl]indazole |
| 05/11/2006 | CA2586174A1 Methods of preparing indazole compounds |
| 05/11/2006 | CA2586033A1 The use of a protease or a protease inhibitor for the manufacture of medicaments |
| 05/11/2006 | CA2585934A1 Novel pyrazolopyridine urea kinase inhibitors |
| 05/11/2006 | CA2585840A1 Use of an mtor inhibitor in treatment of uterine leiomyoma |
| 05/11/2006 | CA2585754A1 Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostics and therapy |
| 05/11/2006 | CA2584681A1 Pearmease and suicide genes for antitumoral or antiviral treatment |
| 05/11/2006 | CA2583570A1 Combination comprising zd6474 and an antiandrogen |
| 05/10/2006 | EP1655605A2 Treatment and diagnosis of cancer |
| 05/10/2006 | EP1655382A2 Colon specific gene and protein |
| 05/10/2006 | EP1655372A2 Production of polyketides and other natural products |
| 05/10/2006 | EP1655369A1 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 05/10/2006 | EP1655305A2 Therapeutic anti-cytomegalovirus compounds |
| 05/10/2006 | EP1655289A1 Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives |
| 05/10/2006 | EP1655284A1 2-Phenylsulfopyrroles |
| 05/10/2006 | EP1655039A2 Immunoliposomes that optimize internalization into target cells |
| 05/10/2006 | EP1655038A1 Target-directed and enteric absorption-controlled liposome having sugar chain and cancer remedy and diagnostic containing the same |
| 05/10/2006 | EP1655036A1 Method for treating oncological diseases |
| 05/10/2006 | EP1654380A2 Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof |
| 05/10/2006 | EP1654377A2 Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER |
| 05/10/2006 | EP1654353A2 Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses threreof |
| 05/10/2006 | EP1654349A2 Sulfs as modifiers of the beta catenin pathway and methods of use |
| 05/10/2006 | EP1654287A2 Cd20-binding polypeptide compositions |
| 05/10/2006 | EP1654257A1 Aminopyrones and their use as atm inhibitors |
| 05/10/2006 | EP1654245A1 Benzofuran derivatives useful for treating hyper-proliferative disorders |
| 05/10/2006 | EP1654236A1 Naphthylene derivatives as cytochrome p450 inhibitors |
| 05/10/2006 | EP1654220A1 Compounds for modulating cell proliferation |
| 05/10/2006 | EP1653992A1 Use of a vegf antagonist in combination with radiation therapy |
| 05/10/2006 | EP1653990A1 Use of polypeptides of the cupredoxin family in cancer therapy |
| 05/10/2006 | EP1653975A1 Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers |
| 05/10/2006 | EP1653973A1 Combinations comprising staurosporines |
| 05/10/2006 | EP1653967A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 05/10/2006 | EP1653964A1 Cancer combination therapy comprising azd2171 and zd1839 |
| 05/10/2006 | EP1653961A1 Inhibitors of akt activity |
| 05/10/2006 | EP1653957A1 Piperidine compounds useful as malonyl-coa decarboxylase inhibitors |
| 05/10/2006 | EP1653951A1 Benzimidazole derivatives as raf kinase inhibitors |
| 05/10/2006 | EP1653946A2 Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein kinase inhibitors |
| 05/10/2006 | EP1653944A1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors |
| 05/10/2006 | EP1653943A2 Compounds and methods for inducing apoptosis in cancer cells |
| 05/10/2006 | EP1653940A1 Therapeutic combination of a cox-2 inhibitor and an aromatase inhibitor |
| 05/10/2006 | EP1653912A2 Vaccine immunotherapy for immune suppressed patients |
| 05/10/2006 | EP1495006A4 Inhibitors of glycinamide ribonucleotide transformylase |
| 05/10/2006 | EP1483374B1 Use of l-alpha-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vitro |
| 05/10/2006 | EP1418911B1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 05/10/2006 | EP1379694B1 Methods and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 05/10/2006 | EP1370553B1 Rho-kinase inhibitors |
| 05/10/2006 | EP1294874B1 Cd154 variants and uses thereof |
| 05/10/2006 | EP1290012B1 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives |
| 05/10/2006 | EP1282641B1 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector |
| 05/10/2006 | EP1212296B9 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 05/10/2006 | EP1210355B1 Glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 05/10/2006 | EP1154798B1 Molecules for the treatment and diagnosis of tumors |
| 05/10/2006 | EP1150696B1 Genetically engineered herpes virus for the treatment of tumours |
| 05/10/2006 | EP1145001B1 (in vitro) model for gastrointestinal inflammation |
| 05/10/2006 | EP1140786B9 Reductive alkylation of secondary amines with hydrosilane |
| 05/10/2006 | EP1104403B1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 05/10/2006 | EP1003548B1 Device for inducing a ctl response |
| 05/10/2006 | EP0873049B1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 05/10/2006 | CN1771325A Compounds and their use for specific and simultaneous inhibition of genes involved in diseases and related drugs |
| 05/10/2006 | CN1771263A Modified acacia and use thereof |